Ibrutinib, idelalisib and obinutuzumab for the treatment of...

  • Main
  • 2015 / 07
  • Ibrutinib, idelalisib and obinutuzumab for the treatment of...

Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target

Morabito, Fortunato, Gentile, Massimo, Seymour, John F., Polliack, Aaron
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2015.1061193
Date:
July, 2015
File:
PDF, 2.97 MB
english, 2015
Conversion to is in progress
Conversion to is failed